NYSE: CATX - Perspective Therapeutics, Inc.

六个月盈利: -80.26%
股息率: 0.00%
部门: Healthcare

促销时间表 Perspective Therapeutics, Inc.


关于公司 Perspective Therapeutics, Inc.

Perspective Therapeutics, Inc., together with its subsidiaries, develops, manufactures, and sells isotope-based medical products and devices for the treatment of cancer and other malignant diseases in the United States and internationally. The company offers CS-1 Cesium-131 brachytherapy seeds for the treatment of prostate, brain, lung, head and neck, gynecological, pelvic/abdominal, and colorectal cancers. It sells its products to facilities or physician practices that utilize various surgical facilities. The company was formerly known as Isoray, Inc.

更多详情
and changed its name to Perspective Therapeutics, Inc. in February 2022. Perspective Therapeutics, Inc. was founded in 1998 and is based in Richland, Washington.

IPO date 2005-11-10
ISIN US46489V1044
Industry Health Care Equipment & Supplies
Sector Health Care
Валюта usd
Валюта отчета usd
Сайт https://www.perspectivetherapeutics.com
Цена ао 2.62
每日价格变化: -1.15% (2.62)
每周价格变化: -0.7663% (2.61)
每月价格变化: -14.52% (3.03)
3个月内价格变化: -25.57% (3.48)
六个月内的价格变化: -80.26% (13.12)
每年价格变化: +142.06% (1.07)
3年内价格变化: +640% (0.35)
5年内价格变化: +181.52% (0.92)
10年价格变化: 0% (2.59)
年初以来价格变化: -21.28% (3.29)

低估

姓名 意义 年级
P/S 133.02 1
P/BV 17.29 1
P/E 0 0
EV/EBITDA -62.27 0
全部的: 0.875

效率

姓名 意义 年级
ROA, % -25.25 0
ROE, % -26.85 0
全部的: 0

股息

姓名 意义 年级
Div yield, % 0 0
DSI 0 0
全部的: 0

责任

姓名 意义 年级
Debt/EBITDA -0.1163 10
全部的: 9.6

成长冲动

姓名 意义 年级
盈利能力 Revenue, % -2.68 0
盈利能力 Ebitda, % 179.96 10
盈利能力 EPS, % 42.79 6
全部的: 7.2

ETF 分享, % 本年盈利能力, % 股息, %
iShares Russell 2000 Growth ETF 0.04295 38.04 0.6026
iShares Morningstar Small-Cap Growth ETF 0.02697 33.63 0.72598
iShares Morningstar Small-Cap Growth ETF 0.02697 587.89 0.72598
iShares Morningstar Small-Cap ETF 0.01351 30.1 1.60498
iShares Morningstar Small-Cap ETF 0.01351 391.25 1.60498
iShares Russell 3000 ETF 0.00132 24.83 1.43482



导师 职称 支付 出生年份
Mr. Johan M. Spoor CEO & Director 855.78k 1972 (53 年)
Mr. Jonathan R. Hunt CFO and Principal Financial & Accounting Officer 944.35k 1967 (58 年)
Mr. Shane Cobb Executive Vice President of Operations N/A
Dr. Michael K. Schultz Ph.D. Chief Science Officer N/A
Mr. Andrew Bright Executive Vice President of Brachytherapy N/A
Dr. Markus Puhlmann M.B.A., M.D. Chief Medical Officer 633.14k 1966 (59 年)
Mr. Amos Hedt BA, PGradDip Chief Business Strategy Officer N/A
Dr. Frances L. Johnson M.D. Chief Innovation Officer N/A
Mr. David Hauser Ph.D. Senior Vice President of Clinical Operations N/A
Steve Keefe Senior Vice President of Clinical Development

地址: United States, Richland. WA, 350 Hills Street - 在 Google 地图中打开, 打开 Yandex 地图
网站: https://www.perspectivetherapeutics.com